0.000
0.00 (0.00%)
| Previous Close | 0.000 |
| Open | 0.000 |
| Volume | 59 |
| Avg. Volume (3M) | 288 |
| Market Cap | 3,001 |
| Price / Book | 0.590 |
| 52 Weeks Range | |
| Earnings Date | 4 Jun 2025 - 13 Jun 2025 |
| Profit Margin | -76.22% |
| Operating Margin (TTM) | -56.47% |
| Diluted EPS (TTM) | -1.19 |
| Quarterly Revenue Growth (YOY) | 8.50% |
| Current Ratio (MRQ) | 0.460 |
| Operating Cash Flow (TTM) | -3.76 M |
| Return on Assets (TTM) | -25.25% |
| Return on Equity (TTM) | -272.89% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Packaged Foods (US) | Mixed | Bearish |
| Packaged Foods (Global) | Mixed | Bearish | |
| Stock | RiceBran Technologies | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | 0.00 |
|
RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company in the United States and internationally. It focuses on development, production, and marketing of products derived from rice and other small and ancient grains for the nutraceutical, healthy food, companion animal, and equine feed categories. The company converts raw rice bran into stabilized rice bran (SRB) and high value SRB derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious, carbohydrate, and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends. It serves food and animal nutrition manufacturers, wholesalers, and retailers. The company was formerly known as NutraCea and changed its name to RiceBran Technologies in October 2012. RiceBran Technologies was founded in 2000 and is headquartered in Tomball, Texas. |
|
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| % Held by Insiders | 4.92% |
| % Held by Institutions | 22.21% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |